We serve Chemical Name:3-pyrrolidin-1-ylpropanehydrazide CAS:59737-32-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:3-pyrrolidin-1-ylpropanehydrazide
CAS.NO:59737-32-5
Synonyms:3-Pyrrolidino-propionsaeure-hydrazid;3-pyrrolidin-1-ylpropanohydrazide;3-pyrrolidino-propionic acid hydrazide
Molecular Formula:C7H15N3O
Molecular Weight:157.21300
HS Code:2933990090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:344.7ºC at 760 mmHg
Density:1.095g/cm3
Index of Refraction:1.513
PSA:58.36000
Exact Mass:157.12200
LogP:0.49130
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 3-Pyrrolidino-propionsaeure-hydrazid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-pyrrolidino-propionic acid hydrazide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-Pyrrolidino-propionsaeure-hydrazid Use and application,3-pyrrolidin-1-ylpropanohydrazide technical grade,usp/ep/jp grade.
Related News: In addition, a high-standard GMP workshop is under construction and is expected to be put into production within the year. As the capacity bottleneck is broken, the pharmaceutical intermediate business is expected to grow rapidly in the future, providing the company with new growth momentum. 3-pyrrolidin-1-ylpropanehydrazide manufacturer Catalent, a global leader in clinical supply services, recently announced the launch of its new CTSuccessTM clinical trial planning service, designed to support trial sponsors with earlier, more proactive and robust clinical supply chain planning, and reduce the risk of delays and budget overspend common to clinical trials as they progress. 3-pyrrolidin-1-ylpropanehydrazide supplier A combination of Imbruvica and AbbVie and Roche’s Venclexta slashed the risk of cancer progression or death by 78.4% compared with a cocktail of Roche’s Gazyva and the chemotherapy chlorambucil in previously untreated CLL. The data, from the phase 3 GLOW trial, were shared at the European Hematology Association (EHA) annual meeting. 3-pyrrolidin-1-ylpropanehydrazide vendor ��The number of confirmed cases of coronavirus in Taiwan is not higher than in most countries affected,�� Mr. Wu said. ��Other than China, no other country, no other country has had its flight banned by Italy.�� 3-pyrrolidin-1-ylpropanehydrazide factory Catalent, a global leader in clinical supply services, recently announced the launch of its new CTSuccessTM clinical trial planning service, designed to support trial sponsors with earlier, more proactive and robust clinical supply chain planning, and reduce the risk of delays and budget overspend common to clinical trials as they progress.
